Immunic, Inc. - Common Stock — キャッシュフロー (NASDAQ:IMUX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -46.12 M-83.23 M-65.14 M-70.83 M-84.77 M-85.81 M -81.33 M 投資活動によるキャッシュフロー -146 K-67 K-9.74 M9.46 M-264 K-161 K -116 K 財務活動によるキャッシュフロー 144.43 M42.84 M95.76 M1.03 M74.54 M65.58 M 254.22 M フリーキャッシュフロー -46.12 M-83.23 M-65.14 M-70.83 M-84.77 M-85.97 M -81.45 M

ニュース

EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO - Immunic (NASDAQ:IMUX)

Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)

Immunic: Saved By A 200 Million Private Placement (NASDAQ:IMUX)

アマゾン株、26%超上昇も？木曜日のトップアナリスト予想トップ10銘柄

Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested - TipRanks.com

What's Going On With Immunic Stock Friday? - Immunic (NASDAQ:IMUX)

Immunic, Inc. (IMUX) Presents at 8th Annual Neuroimmunology Drug Development Summit - Slideshow (NASDAQ:IMUX) 2026-04-16

Immunic stock initiated at Buy by Guggenheim on MS therapy potential

Immunic、Leerink Global Healthcare Conferenceで多発性硬化症治療薬の戦略的見解を提示

Immunic at Leerink Global Healthcare Conference: Strategic Insights on MS Drug

Immunic、ビドフルジムスカルシウムの投与法に関する欧州特許を取得

Immunic secures European patent for vidofludimus calcium dosing